IL-33, IL-25, and ECP Levels were Decreased in Severe Persistent Allergic Asthma Patients with the Anti-IgE (Omalizumab) Treatment
(Thorac Res Pract 2019; 20: 236-236) DOI: 10.5152/TurkThoracJ.2019.236
(Thorac Res Pract 2019; 20: 236-236) DOI: 10.5152/TurkThoracJ.2019.236
(Thorac Res Pract 2019; 20: 237-237) DOI: 10.5152/TurkThoracJ.2019.237